Carregant...
Contrasting Activities of Estrogen Receptor Beta Isoforms in Triple Negative Breast Cancer
PURPOSE. Triple negative breast cancer (TNBC), an aggressive subtype of breast cancer, lacks the three major receptors for predicting outcome or targeting therapy. Hence, our aim was to evaluate the potential of estrogen receptor beta (ERβ) as a possible endocrine therapy target in TNBC. METHODS. Th...
Guardat en:
| Publicat a: | Breast Cancer Res Treat |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7867590/ https://ncbi.nlm.nih.gov/pubmed/33001337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-020-05948-0 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|